4//SEC Filing
KNIGHT PETER S 4
Accession 0001493152-22-034466
CIK 0001712762other
Filed
Dec 4, 7:00 PM ET
Accepted
Dec 5, 4:12 PM ET
Size
21.3 KB
Accession
0001493152-22-034466
Insider Transaction Report
Form 4
KNIGHT PETER S
Director
Transactions
- Purchase
Common Stock, par value $0.007
2022-08-31+8,163→ 22,448 total - Purchase
Warrants (right to buy)
2022-08-31+8,163→ 8,163 totalExercise: $7.35From: 2022-08-31Exp: 2027-08-31→ Common Stock (8,163 underlying) - Purchase
Non-tradeable Warrants (right to buy)
2022-08-31+8,163→ 8,163 totalExercise: $7.66From: 2022-08-31Exp: 2027-08-31→ Common Stock (8,163 underlying)
Footnotes (2)
- [F1]The number of securities and exercise prices reported in this Form 4 reflect the 1-for-7 reverse stock split of the common stock, par value $0.007 (the "Common Stock"), of bioAffinity Technologies, Inc. (the "Issuer"), which became effective with the State of Delaware on June 23, 2022 in connection with the Issuer's initial public offering (the "IPO").
- [F2]The reported securities are included within 8,163 Units purchased by Mr. Knight for $6.125 per Unit in the Issuer's IPO. Each Unit consists of one share of Common Stock, one five-year tradeable warrant to purchase one share of Common Stock at an exercise price of $7.35 per share, and one five-year non-tradeable warrant to purchase one share of Common Stock at an exercise price of $7.656 per share.
Documents
Issuer
bioAffinity Technologies, Inc.
CIK 0001712762
Entity typeother
Related Parties
1- filerCIK 0001189792
Filing Metadata
- Form type
- 4
- Filed
- Dec 4, 7:00 PM ET
- Accepted
- Dec 5, 4:12 PM ET
- Size
- 21.3 KB